Product Information
Name:ORY-1001
Brand:Biosynth
Description:Ory-1001 is a monoclonal antibody that binds to the HL-60 leukemia cell surface protein CD22, which is a receptor for the B-cell growth factor. Ory-1001 inhibits the binding of this growth factor to its receptor, thereby inhibiting cell proliferation and migration. Ory-1001 has been shown to eradicate leukemic stem cells in vivo and inhibit tumor growth in vitro. The drug has also been shown to have cardioprotective properties, likely due to its ability to inhibit the production of cardiac growth factors.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:230.35 g/mol
Formula:C15H22N2·2HCl
Purity:Min. 95%
Technical inquiry about: ORY-1001
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.